跳至主要内容
临床试验/NCT04081402
NCT04081402Unknown3 期

A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines

Huons Co., Ltd.2 个研究点 分布在 2 个国家目标入组 290 人开始时间: 2018年11月1日最近更新:
适应症

试验速览

阶段
3 期
入组人数
290
试验地点
2
主要终点
Change from Baseline of Crow's feet Lines improvement rate [Time Frame: Week 4]

研究概览

简要总结

A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Bilaterally symmetrical moderate-to-severe CFL at maximum smile on the FWS as rated by the investigator

排除标准

  • Volunteer who has history of any diseases following. (myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis etc.)
  • From screening, Subject who get a plastic Surgery within 48 Weeks
  • Subject who has skin disorder including infection and scar on injection site
  • Subject who takes a medication including skeletal muscle relaxants, Aminoglycoside, lincomycin, anticholinergic drug, benzodiazepine, benzamide etc.
  • Subject who takes a medication including anticoagulant, antithrombotic drug except low dose aspirin (below 325 mg/day)
  • Any condition that, in the view of the investigator, would interfere with study participation

结局指标

主要结局

Change from Baseline of Crow's feet Lines improvement rate [Time Frame: Week 4]

时间窗: 4 weeks

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

A Phase 1/3 Clinical Trial to Evaluate the Safety... | 临床试验